Center Laboratories, Inc. (TPEX:4123)
Taiwan · Delayed Price · Currency is TWD 41.70
-0.30 (-0.71%)
Apr 2, 2026, 1:30 PM CST
Center Laboratories Market Cap
Center Laboratories has a market cap or net worth of 31.13 billion as of April 2, 2026. Its market cap has increased by 7.22% in one year.
Market Cap
31.13B
Enterprise Value
35.17B
Revenue
1.52B
Ranking
n/a
PE Ratio
3.64
Stock Price
41.70
Market Cap Chart
Since November 3, 2004, Center Laboratories's market cap has increased from 358.01M to 31.13B, an increase of 8,595.30%. That is a compound annual growth rate of 23.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 31.13B | 0.24% |
| Dec 31, 2025 | 31.06B | -1.69% |
| Dec 31, 2024 | 31.59B | 3.14% |
| Dec 29, 2023 | 30.63B | 8.88% |
| Dec 30, 2022 | 28.13B | -7.93% |
| Dec 30, 2021 | 30.56B | -3.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 57.02B |
| Lotus Pharmaceutical | 56.77B |
| TTY Biopharm Company | 18.30B |
| ScinoPharm Taiwan | 17.91B |
| Grape King Bio | 17.85B |
| Synmosa Biopharma | 15.55B |
| YungShin Global Holding | 14.78B |
| Foresee Pharmaceuticals | 12.13B |